Kunkel Lori Anne

Chief Medical Officer at PHARMACYCLICS INC · on record since Dec 5, 2011
Director at Enliven Therapeutics, Inc. · on record since Jun 9, 2026
Director at CURIS INC · on record since Nov 14, 2016
Director at Loxo Oncology, Inc. · on record since Oct 29, 2014
Director at Forte Biosciences, Inc. · on record since Apr 12, 2017
Acting-Chief Medical Officer at Forte Biosciences, Inc. · on record since Feb 26, 2019
Director at Oric Pharmaceuticals, Inc. · on record since Jun 10, 2020
Director at Nurix Therapeutics, Inc. · on record since Jul 23, 2020

Insider trading activity of Kunkel Lori Anne

Transactions on record: 82; since Dec 5, 2011

Open-market buys: 0

Open-market sells: 21; $10.6M

Companies traded: 7; last filing Jul 8, 2026

Figures computed from official regulatory filings — .

Companies where Kunkel Lori Anne has traded

Enliven Therapeutics, Inc.10 tx · $868.1K · Jul 8, 2026
Oric Pharmaceuticals, Inc.17 tx · $410.1K · Jan 6, 2026
Nurix Therapeutics, Inc.6 tx · May 19, 2025
CURIS INC8 tx · $15.5K · Jan 31, 2022
Forte Biosciences, Inc.5 tx · Oct 4, 2019
Loxo Oncology, Inc.33 tx · $34.6M · Feb 15, 2019
PHARMACYCLICS INC3 tx · $42.5K · May 1, 2013

Track record of Kunkel Lori Anne

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kunkel Lori Anne

Co-insiders of Kunkel Lori Anne

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Jul 8, 2026	Sell	-4,111	49.98 USD	$205.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jul 8, 2026	Sell	-5,889	50.84 USD	$299.4K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-354	35.82 USD	$12.7K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-1,867	35.36 USD	$66K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-7,779	34.28 USD	$266.7K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	17,126	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 19, 2025	ExerciseD (derivative)	-15,958	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 19, 2025	Exercise	15,958	1.12 USD	$17.9K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 9, 2025	Exercise	10,000	7.90 USD	$79K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 9, 2025	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 5, 2025	Exercise	5,534	3.75 USD	$20.8K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 5, 2025	ExerciseD (derivative)	-5,534	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nurix Therapeutics, Inc.Listing on record	May 19, 2025	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	Exercise	20,500	6.33 USD	$129.8K	Unusual size	SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	ExerciseD (derivative)	-20,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	Exercise	27,666	3.75 USD	$103.7K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	ExerciseD (derivative)	-27,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 10, 2025	AwardD (derivative)	15,368	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2025	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nurix Therapeutics, Inc.Listing on record	Jul 18, 2024	Gift	-54,027	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	25,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 4, 2024	ExerciseD (derivative)	-20,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 4, 2024	Exercise	20,500	3.75 USD	$76.9K		SEC
Nurix Therapeutics, Inc.Listing on record	May 20, 2024	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Jul 8, 2026	Sell	-4,111	49.98 USD	$205.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jul 8, 2026	Sell	-5,889	50.84 USD	$299.4K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-354	35.82 USD	$12.7K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-1,867	35.36 USD	$66K		SEC
Enliven Therapeutics, Inc.Listing on record	Jun 9, 2026	Sell	-7,779	34.28 USD	$266.7K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	17,126	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 19, 2025	ExerciseD (derivative)	-15,958	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Dec 19, 2025	Exercise	15,958	1.12 USD	$17.9K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 9, 2025	Exercise	10,000	7.90 USD	$79K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 9, 2025	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 5, 2025	Exercise	5,534	3.75 USD	$20.8K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Dec 5, 2025	ExerciseD (derivative)	-5,534	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nurix Therapeutics, Inc.Listing on record	May 19, 2025	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	Exercise	20,500	6.33 USD	$129.8K	Unusual size	SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	ExerciseD (derivative)	-20,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	Exercise	27,666	3.75 USD	$103.7K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Mar 4, 2025	ExerciseD (derivative)	-27,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 10, 2025	AwardD (derivative)	15,368	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2025	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nurix Therapeutics, Inc.Listing on record	Jul 18, 2024	Gift	-54,027	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	25,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 4, 2024	ExerciseD (derivative)	-20,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jun 4, 2024	Exercise	20,500	3.75 USD	$76.9K		SEC
Nurix Therapeutics, Inc.Listing on record	May 20, 2024	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC